simvastatin has been researched along with Cerebral Malaria in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobs, T; Kobbe, R; May, J; Schreiber, N | 1 |
| Bienvenu, AL; Picot, S | 1 |
| Gowda, DC; Helmers, AJ; Kain, KC; Liles, WC | 1 |
3 other study(ies) available for simvastatin and Cerebral Malaria
| Article | Year |
|---|---|
Simvastatin treatment shows no effect on the incidence of cerebral malaria or parasitemia during experimental malaria.
Topics: Animals; Disease Models, Animal; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Malaria, Cerebral; Mice; Mice, Inbred C57BL; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Simvastatin; Treatment Outcome | 2008 |
Statins alone are ineffective in cerebral malaria but potentiate artesunate.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Atorvastatin; Disease Models, Animal; Drug Synergism; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Malaria, Cerebral; Malaria, Falciparum; Mice; Neuroprotective Agents; Pravastatin; Pyrroles; Simvastatin | 2008 |
Statins fail to improve outcome in experimental cerebral malaria and potentiate Toll-like receptor-mediated cytokine production by murine macrophages.
Topics: Animals; Antimalarials; Cells, Cultured; Gene Expression Regulation; Humans; Interleukin-6; Macrophages, Peritoneal; Malaria, Cerebral; Mice; Mice, Inbred C57BL; Parasitemia; Plasmodium berghei; Simvastatin; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2009 |